Designed as a comprehensive course, this didactic conference educates scientists on the processes of translating basic research into novel therapies and leaves participants with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug. The programs also highlight case studies of small molecule and biologics programs at different stages of development aimed at tackling challenging CNS targets relevant to neurodegeneration. The program includes sessions for networking, partnering/mentoring, and posters presented by young investigators.